Douglas W. Losordo

Chief Medical Officer, Caladrius Biosciences.

Companies

Cadrenal Therapeutics, Inc.Chief Medical Officer Jan 19, 2023 to Jan 19, 2024¹
Longeveron Inc.Board member Feb 11, 2021 to Dec 26, 2023²
Caladrius BiosciencesChief Medical Officer Aug 7, 2013 to Jan 15, 2020³
Caladrius BiosciencesBoard member Aug 1, 2014 to Aug 1, 2014⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCadrenal Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARLongeveron Inc., Board member
3
SEC EDGARCaladrius Biosciences, Chief Medical Officer
4
SEC EDGARCaladrius Biosciences, Board member